Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)
Song et al., The Lancet Regional Health - Americas, doi:10.1016/j.lana.2022.100216
https://c19early.org/song4.html